Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)
NCT01281072 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2011-01-21
Summary
Open label study to evaluate long term treatment effect of diapep277.
Conditions
- Giving a Vaccination in Three Months
Interventions
- OTHER
-
vaccine
Sponsors & Collaborators
-
DIABETES UNIT
collaborator AMBIG -
Hadassah Medical Organization
lead OTHER
Study Design
- Allocation
- NA
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes
NCT07087795 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus
NCT00762112 ·Status: TERMINATED ·Phase: PHASE3
-
Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin
NCT01519674 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
NCT04097600 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus
NCT03015519 ·Status: WITHDRAWN ·Phase: PHASE3
-
DPP4inhibitors in Type 1 Diabetes
NCT01922817 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
NCT02863328 ·Status: COMPLETED ·Phase: PHASE3
-
To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function
NCT05747664 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)
NCT02532855 ·Status: COMPLETED ·Phase: PHASE3
-
Dapagliflozin Effects on Hypoglycemia
NCT03704818 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study to Compare Two Doses of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
NCT03989232 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)
NCT03175120 ·Status: COMPLETED ·Phase: PHASE3
-
DPP-4 Inhibition and TZD for DM Prevention
NCT01006018 ·Status: TERMINATED ·Phase: NA
-
A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.
NCT03169959 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion
NCT00885638 ·Status: COMPLETED ·Phase: PHASE4
-
A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin
NCT02551874 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice
NCT03457012 ·Status: COMPLETED
-
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
NCT02254291 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes
NCT00855166 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes
NCT02054897 ·Status: COMPLETED ·Phase: PHASE3
-
The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)
NCT01106677 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus
NCT00865592 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of SGLT-2 Inhibitor Dapagliflozin on Glycemic Variability in Patients With Diabetes Mellitus Type 2
NCT02719756 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta Cell
NCT02420392 ·Status: COMPLETED ·Phase: NA
-
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
NCT03878706 ·Status: RECRUITING